2-(cyclohexylamino)benzoic acid

2-(cyclohexylamino)benzoic acid Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name 2-(cyclohexylamino)benzoic acid
Generic 2-(cyclohexylamino)benzoic acid
Type
Formula C13H17NO2
Weight Average: 219.2796
Monoisotopic: 219.125928793
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
2-(cyclohexylamino)benzoic acid
2-(cyclohexylamino)benzoic acid

Innovators Monograph

You find simplified version here 2-(cyclohexylamino)benzoic acid



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=19826721
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99443509
https://www.chemspider.com/Chemical-Structure.21514377.html
https://zinc.docking.org/substances/ZINC000021999434
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3B4
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide
N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide
7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide
7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide
3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide
(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide
2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID
N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide
Nerve conduction velocity
Uric acid urine test
Radionuclide cisternogram
Protein S blood test
Dental plaque identification at home
Ultrasound
Ureteral retrograde brush biopsy
Hyperplasia
Electromyography (EMG) and Nerve Conduction Studies
Oropharynx lesion biopsy
Primary Gout
Moderate Scalp Psoriasis
Inflamed External Hemorrhoid
Moderate to Severe Asthma
Osteolysis caused by Bone Tumors
Superficial Thrombophlebitis
Recurrent Mismatch Repair-deficient (dMMR) Endometrial Cancer
Thrombotic events
Necrosis caused by Administration site extravasation
Severe Fungal infection caused by sporotrichosis spp.